Related Experiment Video
Updated: May 19, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
Published on: August 31, 2016
Survival in overweight and underweight children undergoing hematopoietic stem cell transplantation
M White1, A J Murphy, A Hallahan
1Department of Nutrition and Dietetics, Royal Children's Hospital, Herston, Queensland, Australia. Melinda_White@health.qld.gov.au
Insights
Overweight children undergoing hematopoietic stem cell transplantation have reduced survival rates. Nutritional status impacts outcomes for pediatric cancer patients, with overweight status posing a significant risk post-transplant.
Area of Science:
- Pediatric oncology
- Hematopoietic stem cell transplantation
- Nutritional science
Background:
- Nutritional status is increasingly recognized as a factor influencing outcomes in pediatric cancer patients.
- Understanding the impact of pre-transplant nutritional status on survival is crucial for optimizing patient care.
Purpose of the Study:
- To investigate the association between pre-transplant nutritional status and overall survival in children undergoing hematopoietic stem cell transplantation.
- To determine if weight categories (underweight, ideal weight, overweight) correlate with post-transplant survival rates.
Main Methods:
- Retrospective audit of 113 pediatric patients undergoing autologous or allogeneic hematopoietic stem cell transplant.
- Patients categorized into underweight, ideal weight, and overweight based on percent ideal body weight.
- Overall post-transplant survival analyzed across weight categories, adjusting for relevant covariates.
Main Results:
- Overweight patients (36%) demonstrated significantly lower survival rates compared to ideal-weight patients (Hazard Ratio 1.91).
- Underweight patients (13%) did not show a statistically significant increase in mortality compared to ideal-weight patients (Hazard Ratio 1.47).
- Key factors adjusted for included age, sex, donor source, conditioning therapy, and year of transplant.
Conclusions:
- Pre-transplant overweight status is associated with decreased survival in children following hematopoietic stem cell transplantation.
- Maintaining an ideal body weight prior to transplantation may be beneficial for improving survival outcomes in pediatric patients.
Background/Objectives:
There is a growing body of evidence that nutritional status influences the morbidity and mortality of children undergoing treatment for cancer. The aim of this paper is to determine if nutritional status is associated with survival post-pediatric bone marrow transplant.
Subjects/Methods:
This was a single-center retrospective audit of patients who underwent an autologous or allogeneic hematopoietic stem cell transplant. Patients were divided into three weight categories of underweight, ideal weight and overweight defined by percent ideal body weight. The outcome of interest, overall post transplant survival, was compared between weight categories.
Results:
Of 113 patients, 15 (13%) were underweight and 41 (36%) were classified as overweight. After adjustment for age, sex, donor source, conditioning therapy and year of transplant, overweight patients were significantly less likely to survive than ideal-weight patients (hazard ratio (HR) 1.91; 95% confidence interval, 1.10-3.31). There was no significant increase in mortality when underweight patients were compared with ideal-weight patients (HR 1.47; 95% confidence interval, 0.57-3.79).
Conclusions:
Children who are overweight before hematopoietic stem cell transplantation have decreased survival compared with ideal-weight children.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Regulation of Hematopoietic Stem Cells
Multipotency of Hematopoietic Stem Cells
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Kidney Transplant I: Introduction
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

